Hematopoietic Stem Cell Mobilization outcomes following Rituximab ± ICE in Relapsed or Refractory Lymphomas. // Transfusion and Apheresis Science. – URL: https://www.sciencedirect.com/science/article/pii/S1473050226001989?dgcid=rss_sd_all
Hematopoietic Stem Cell Mobilization outcomes following Rituximab ± ICE in Relapsed or Refractory Lymphomas. Transfusion and Apheresis Science. https://www.sciencedirect.com/science/article/pii/S1473050226001989?dgcid=rss_sd_all
“Hematopoietic Stem Cell Mobilization outcomes following Rituximab ± ICE in Relapsed or Refractory Lymphomas.” Transfusion and Apheresis Science.
@article{article70052,
title = {Hematopoietic Stem Cell Mobilization outcomes following Rituximab ± ICE in Relapsed or Refractory Lymphomas},
journal = {Transfusion and Apheresis Science},
url = {https://www.sciencedirect.com/science/article/pii/S1473050226001989?dgcid=rss_sd_all}
}